PODCAST · health
Optimizing Treatment in Patients with ROS1 Rearranged NSCLC
by Annenberg Center for Health Sciences
Greater understanding and implementation of molecular biomarkers in non-small cell lung cancer (NSCLC) have led to improved patient outcomes. However, optimizing therapeutic strategies for patients with a molecular alteration continues to be challenging for the multidisciplinary team. Among these alterations, ROS1 rearrangements are rare, but have important clinical implications.
-
1
Introduction and Key Takeaways
This full educational program can be accessed at no cost here: https://annenberg.net/courses/landingPage.php?courseID=61030
We're indexing this podcast's transcripts for the first time — this can take a minute or two. We'll show results as soon as they're ready.
No matches for "" in this podcast's transcripts.
No topics indexed yet for this podcast.
Loading reviews...
ABOUT THIS SHOW
Greater understanding and implementation of molecular biomarkers in non-small cell lung cancer (NSCLC) have led to improved patient outcomes. However, optimizing therapeutic strategies for patients with a molecular alteration continues to be challenging for the multidisciplinary team. Among these alterations, ROS1 rearrangements are rare, but have important clinical implications.
HOSTED BY
Annenberg Center for Health Sciences
Loading similar podcasts...